Shows improved tumor imaging with a zirconium probe, suggesting better detection methods.
Aza-boron-dipyrromethenes (aza-BODIPYs) are established fluorescent imaging agents derived from aza-DIPY ligands coordinated to boron. While many modifications of the aza-DIPY core have optimized the photophysical properties, replacing boron with a metal ion remains underexplored. Here, we report four zirconium-based aza-DIPY complexes ( aza-ZrDIPYs ) and show that this substitution enables bimodal NIR-I fluorescence and photoacoustic imaging. The complexes were fully characterized and evaluated photophysiologically. The bromo derivative, aza-ZrDIPY-Br, displayed particularly favorable dual-mode properties. It showed low in vitro cytotoxicity and an effective uptake in two human cell lines. In mice bearing subcutaneous U87-MG glioblastoma tumors, intravenous or peritumoral administration led to passive tumor accumulation, with tumor-to-background ratios of up to 5 (photoacoustic) and 2 (optical). These results highlight aza-ZrDIPY-Br as a promising bimodal probe for tumor imaging, with future work aimed at improving specificity through active targeting.
No takes yet. Share an insight, caveat, or question.
Bendellaa et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: